Navigation Links
Musculoskeletal Network Features New Research into the Cause of Rheumatoid Arthritis and Lupus
Date:3/25/2013

NORWALK, Conn., March 25, 2013 /PRNewswire/ -- UBM Medica US announces that Musculoskeletal Network highlights growing evidence supporting the idea that many conditions related to arthritis are caused by cross-reactions between immune responses against infections and damage to the body's own tissues.

Diseases such as rheumatoid arthritis and lupus may be an indication of a defect in the body's ability to fight infection, rather than an over-reaction to it, writes rheumatologist Stephen Paget MD, physician-in-chief emeritus at the Hospital for Special Surgery in New York. Forthcoming research may confirm that, for many people with unexplainable conditions that cause joint pain and swelling, the unrecognized cause is infection, he predicts, pointing to a new focus for prevention and treatment.

Among the evidence behind his startling hypothesis, Dr. Paget points out that:

  • Rheumatoid arthritis has been strongly linked to periodontal disease, bacterial infection of the gums.
  • Some patients affected with Lyme disease, which is caused by a tick-borne bacterium, continue to have joint problems after all evidence of a living bacterium disappears.
  • The bacterium Chlamydia trachomatis, cause of a sexually transmitted disease (STD) that is often asymptomatic, can persist for years within joints, causing inflammation.

New research into the genomes of microorganisms, sponsored by a major government initiative, is revealing many infectious agents that were previously unknown, Dr. Paget points out, and more remain to be discovered.

About UBM Medica US

Addressing today's healthcare information needs, UBM Medica US delivers strategic, integrated communications solutions and comprehensive reach—online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, MusculoskeletalNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect—which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit http://www.UBMMedicaUS.com

Media contact:

Jason J. Golden
Content Marketing Manager
203-523-7040
jason.golden@ubm.com


'/>"/>
SOURCE UBM Medica US
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
2. Musculoskeletal Network Features Update on Nutraceuticals for Osteoarthritis
3. GNS Healthcare Joins Orion Bionetworks to Develop Predictive Models for Multiple Sclerosis and Other Diseases
4. VIC Investor Network to Significantly Accelerate Technology Company Growth
5. Researchers create building block of quanutm networks
6. Secretary of Department of Environmental Protection, Michael Krancer, to Facilitate Networking Session at Pittcon 2013
7. MDA Launches Clinical Network to Speed Myotonic Dystrophy Research
8. Notre Dame to be part of $194 million university research center network
9. House to Vote on Post-Sandy Mold Relief Fund Next Week; Dr Mold Network Comments Amount is Truly Needed by Hurricane Victims
10. Mold Linked With Fatal Asthma and Allergy Attacks; Dr Mold Network Suggests Use of Molderizer and Safe Shield for Safer Mold Treatment
11. Possible Mold Infestation at Queens School Worries Parents; Doctor Mold Network Suggests a Mold Spray for a Safe and Effective Mold Remediation Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN RAFAEL, Calif., Feb. 23, 2017 ... of U.S. dollars, except per share data, unaudited)Three Months ... ChangeTotal BioMarin Revenue $ ...     22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... during the 12th annual Inventors Recognition Reception at Purdue Research Park ... a faculty member in recognition of outstanding contributions to, and success with, commercializing ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):